SLC2A1 and neoplasm: Increased plasma and tumor vitamin C levelsDecreased tumor development and growthIncreased collagen encapsulation and decreased metastasisDecreased pro-survival protein levels (e.g., HIF-1α, GLUT-1, VEGF)Decreased pro-inflammatory cytokines (e.g., IL-6, IL-1β)